$AGNPF News

Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

Algernon Closes Second Tranche of Private Placement Financing

Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

Algernon Health Announces Private Placement

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Algernon Pharmaceuticals Completes Name Change to Algernon Health

Catalyst MedTech Launches "Connect" Program to Expand Access to Advanced Imaging; Announces Initial Partnership with Algernon Pharmaceuticals

Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection

Algernon Announces Preferred Share Class Approved at Annual and Special Meeting

Algernon Pharmaceuticals Announces Name Change to Algernon Health

Algernon Announces Closing of the Private Placement Financing

Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000

Algernon Announces $1M Private Placement

Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition

Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer’s Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology

Algernon Announces Warrant Extension

Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease

Algernon NeuroScience Engages Netcapital Securities for Planned Regulation A Financing